Nicox S.A.
Ophthalmology company developing therapies based on a nitric oxide-donating platform.
COX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013018124 (+6 more)
- LEI:
- 969500EZGEO9W4JXR353
- Country:
- France
- Address:
- SOPHIA, 06410 BIOT
- Website:
- https://www.nicox.com/
Description
Nicox S.A. is an international ophthalmology company focused on the research and development of innovative therapeutic solutions to maintain vision and improve ocular health. The company's lead product candidate is NCX 470, a novel nitric oxide (NO)-donating bimatoprost analog in late-stage clinical development for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Nicox's pipeline is based on its proprietary NO-donating research platform. The company has also developed two approved ophthalmic products: VYZULTA® (latanoprostene bunod ophthalmic solution), licensed exclusively to Bausch + Lomb, and ZERVIATE® (cetirizine ophthalmic solution), licensed to various partners for commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-07-19 07:30 |
Nicox Provides Second Quarter 2023 Financial and Business Highlights
|
English | 83.3 KB | ||
| 2023-07-11 07:30 |
Nicox : Bilan semestriel du contrat de liquidité avec Kepler Cheuvreux
|
French | 149.5 KB | ||
| 2023-07-11 07:30 |
Nicox: Half-year liquidity contract statement with Kepler Cheuvreux
|
English | 145.4 KB | ||
| 2023-07-10 07:30 |
Nicox : Potentiel chiffre d'affaires net mondial annuel du NCX 470 estimé à plu…
|
French | 89.9 KB | ||
| 2023-07-10 07:30 |
Nicox Estimates Potential Annual Global Net Sales for NCX 470 of over $300 mill…
|
English | 80.0 KB | ||
| 2023-07-03 17:45 |
MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF …
|
English | 119.8 KB | ||
| 2023-07-03 17:45 |
MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF …
|
French | 119.7 KB | ||
| 2023-07-03 07:30 |
Nicox Presented NCX 470 Phase 3 Mont Blanc Adaptive Design Data and Additional …
|
English | 182.4 KB | ||
| 2023-07-03 07:30 |
Nicox : Présentation au Congrès Mondial du Glaucome de données sur le NCX 470 p…
|
French | 224.3 KB | ||
| 2023-06-02 07:30 |
Nicox: 2023 Ordinary Shareholder Meeting
|
English | 64.5 KB | ||
| 2023-06-02 07:30 |
Nicox : Assemblée Générale Ordinaire 2023
|
French | 74.4 KB | ||
| 2023-06-01 18:30 |
Monthly Publication of the Number of Shares Composing the Share Capital and of …
|
English | 78.2 KB | ||
| 2023-06-01 18:30 |
PUBLICATION MENSUELLE DU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOT…
|
French | 78.5 KB | ||
| 2023-05-03 17:45 |
Nombre de droits de vote au 30 avril 2023
|
French | 119.1 KB | ||
| 2023-05-03 17:45 |
Number of voting rights as of April 30, 2023
|
English | 119.5 KB |
Automate Your Workflow. Get a real-time feed of all Nicox S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nicox S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nicox S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
